ArticleCancers2021

Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer.

Isabel Mayayo-Peralta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.